>
Switch to:

Indaptus Therapeutics Quick Ratio

: 3.45 (As of Jun. 2021)
View and export this data going back to 2021. Start your Free Trial

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Indaptus Therapeutics's quick ratio for the quarter that ended in Jun. 2021 was 3.45.

Indaptus Therapeutics has a quick ratio of 3.45. It generally indicates good short-term financial strength.

The historical rank and industry rank for Indaptus Therapeutics's Quick Ratio or its related term are showing as below:

NAS:INDP' s Quick Ratio Range Over the Past 10 Years
Min: 0.86   Med: 2.16   Max: 3.45
Current: 3.45

0.86
3.45

During the past 0 years, Indaptus Therapeutics's highest Quick Ratio was 3.45. The lowest was 0.86. And the median was 2.16.

NAS:INDP's Quick Ratio is ranked lower than
99.99% of the 316 Companies
in the Biotechnology industry.

( Industry Median: 4.09 vs. NAS:INDP: 3.45 )

Indaptus Therapeutics Quick Ratio Historical Data

The historical data trend for Indaptus Therapeutics's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indaptus Therapeutics Annual Data
Trend
Quick Ratio

Indaptus Therapeutics Quarterly Data
Jun20 Mar21 Jun21
Quick Ratio - 0.86 3.45

Competitive Comparison

For the Biotechnology subindustry, Indaptus Therapeutics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Indaptus Therapeutics Quick Ratio Distribution

For the Biotechnology industry and Healthcare sector, Indaptus Therapeutics's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Indaptus Therapeutics's Quick Ratio falls into.



Indaptus Therapeutics Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Indaptus Therapeutics's Quick Ratio for the fiscal year that ended in . 20 is calculated as

Indaptus Therapeutics's Quick Ratio for the quarter that ended in Jun. 2021 is calculated as

Quick Ratio (Q: Jun. 2021 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(18.792-0)/5.44
=3.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indaptus Therapeutics  (NAS:INDP) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Indaptus Therapeutics Quick Ratio Related Terms

Thank you for viewing the detailed overview of Indaptus Therapeutics's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Indaptus Therapeutics Business Description

Indaptus Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 541714 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)